Full Text
Effect of A Tier Change Policy for Biologic Disease Modifying Antirheumatic Drugs (Dmards) On Health Care Cost and Medication Effectiveness

Abstract

Authors

B.J. Chastek F. Liu N. Shah D.J. Harrison

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×